Ocuphire Pharma shareholders elect six directors, ratify auditor, and approve annual say-on-pay vote

Opus Genetics, Inc.

All six director nominees elected: Cam Gallagher, Sean Ainsworth, James Manuso, Richard Rodgers, Susan Benton, Jay Pepose.
Ratification of Ernst & Young as auditor passed with 11,172,192 votes for (99.8% of shares voted).
Advisory vote on frequency of say-on-pay: 'every year' received 4,180,454 votes, board adopts annual frequency.
Approximately 53.60% of outstanding shares represented at meeting (11,228,343 shares).
Broker non-votes of 5,087,873 shares noted for director elections.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Opus Genetics, Inc. shareholders approved Advisory Recommendation on the Frequency of an Advisory Vote on Named Executive Officer Compensation at the 2023-06-06 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Proposal 3 - Advisory Recommendation on the Frequency of an Advisory Vote on Named Executive Officer Compensation One Year Two Years Three Years Votes Abstain 4,180,454 293,529 1,447,777 218,710

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Opus Genetics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-06 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 11,172,192 19,672 36,479

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Opus Genetics, Inc. shareholders approved Election of Directors at the 2023-06-06 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

Proposal 1 - Election of Directors Nominee Votes For Votes Withheld Broker Non-Votes Cam Gallagher 4,488,270 1,652,200 5,087,873 Sean Ainsworth 5,370,425 770,045 5,087,873 James Manuso 5,318,419 822,051 5,087,873 Richard Rodgers 4,538,415 1,602,054 5,087,873 Susan Benton 5,351,488 788,982 5,087,873 Jay Pepose 5,314,552 825,918 5,087,873

View on SEC.gov

347 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Opus Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-029009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.